Galapagos Biotech (an AlfaSigma SpA company)

Galapagos Biotech (an AlfaSigma SpA company)

Galapagos discovers and develops small molecule medicines with novel modes of action, several of which show promising patient results and are currently in clinical development in multiple diseases. Our aim is to make a lasting positive contribution to society through discovery of breakthrough therapies for diseases with large unmet medical need.

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Galapagos Biotech (an AlfaSigma SpA company)
Galapagos Biotech (an AlfaSigma SpA company) Salisbury House, Station Road Cambridge CB1 2LA United Kingdom
Get directions

CPD Subsectors

Scientific Organisations
Scientific Research
Medical
Health & Wellbeing
Pharmaceutical